The Possible Pathological Role of Endogenous Cannabinoid System in Heart Failure Syndrome
Lviv clinical bulletin · 2013
DOI: 10.25040/lkv2013.01.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lviv clinical bulletin, 2013. Verfasst von O. Katerenchuk. Die Arbeit nennt 17 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure is a clinical syndrome associated with the high rates of short-time and long-time mortality. The pathological role of several neurohumoral systems is well-established in heart failure progression. According to the data available from the Basic experiments the role of the endogenous cannabinoid system in heart failure progression is considered. The hyperstimulation with further depletion of CВ1 receptors and mediators results in hypotension, Bradycardia, depression, muscle pain and liver cirrhosis - that usually accompanies the decompensated and end-stage heart failure. Further discovering of CВ1 exogenous agents acting on central nervous system and/or peripheral CВ1 receptors can result in creating the new group of drugs in heart failure treatment.
Zitieren
APA
Katerenchuk, O. (2013). The Possible Pathological Role of Endogenous Cannabinoid System in Heart Failure Syndrome. Lviv clinical bulletin. https://doi.org/10.25040/lkv2013.01.054
Vancouver
Katerenchuk O. The Possible Pathological Role of Endogenous Cannabinoid System in Heart Failure Syndrome. Lviv clinical bulletin. 2013. doi:10.25040/lkv2013.01.054
BibTeX
@article{Katerenchuk2013,
author = {Katerenchuk, O.},
title = {The Possible Pathological Role of Endogenous Cannabinoid System in Heart Failure Syndrome},
journal = {Lviv clinical bulletin},
year = {2013},
doi = {10.25040/lkv2013.01.054}
}
EUVIMED